Bharat Biotech looks to expand phase-III trial base

Hyderabad-based Bharat Biotech is considering expanding phase-III trial of its Covid-19 vaccine candidate Covaxin by adding more sites to the already shortlisted 21, according to people aware of the development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3epOFoV
via IFTTT